Edition:
United States

Johnson & Johnson (JNJ)

JNJ on New York Consolidated

130.31USD
19 Jul 2019
Change (% chg)

$-1.76 (-1.33%)
Prev Close
$132.07
Open
$132.25
Day's High
$132.39
Day's Low
$130.19
Volume
8,340,239
Avg. Vol
6,853,536
52-wk High
$148.99
52-wk Low
$121.00

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer... (more)

Overall

Beta: 0.68
Market Cap(Mil.): $345,980.31
Shares Outstanding(Mil.): 2,655.06
Dividend: 0.95
Yield (%): 2.92

Financials

  JNJ Industry Sector
P/E (TTM): 21.61 30.63 34.52
EPS (TTM): 6.03 -- --
ROI: -- 13.02 12.69
ROE: -- 14.18 17.17

US STOCKS-Wall Street slips as bank earnings, Trump trade comments weigh

* Indexes fall: Dow 0.09%, S&P 0.34%, Nasdaq 0.43% (Updates to market close)

Jul 16 2019

J&J warns of hit from generic drugs in third quarter, shares fall

Johnson & Johnson on Tuesday boosted its 2019 sales forecast amid robust demand for its cancer drugs, but warned that competition from generic and copycat drugs could impact its third-quarter results, sending shares down 1.4% in noon trading.

Jul 16 2019

UPDATE 3-J&J warns of hit from generic drugs in third quarter, shares fall

July 16 Johnson & Johnson on Tuesday boosted its 2019 sales forecast amid robust demand for its cancer drugs, but warned that competition from generic and copycat drugs could impact its third-quarter results, sending shares down 1.4% in noon trading.

Jul 16 2019

Johnson & Johnson quarterly profit jumps 41.8%

July 16 Johnson & Johnson reported a 41.8% rise in second-quarter profit on Tuesday, helped by its pharmaceuticals business.

Jul 16 2019

Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end

NORMAN, Okla. Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible for fueling the U.S. opioid epidemic in the first trial to result from lawsuits over the crisis.

Jul 15 2019

CORRECTED-UPDATE 2-Oklahoma at trial's end says opioid 'kingpin' J&J fueled epidemic

NORMAN, Okla., July 15 Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible for fueling the U.S. opioid epidemic in the first trial to result from lawsuits over the crisis.

Jul 15 2019

Oklahoma, J&J to wrap up first trial over opioid crisis

July 15 Oklahoma's attorney general is expected on Monday to urge a judge to find Johnson & Johnson responsible for flooding the market with painkillers and fueling the U.S. opioid epidemic, as the first trial in nationwide litigation over the drug crisis comes to an end.

Jul 15 2019

J&J faces U.S. criminal probe related to baby powder - Bloomberg

The U.S. Justice Department is pursuing a criminal probe into whether Johnson & Johnson lied about potential cancer risks of its talcum powder and has convened a grand jury in Washington, Bloomberg reported on Friday, citing people with knowledge of the matter.

Jul 12 2019

UPDATE 2-J&J faces U.S. criminal probe related to baby powder - Bloomberg

July 12 The U.S. Justice Department is pursuing a criminal probe into whether Johnson & Johnson lied about potential cancer risks of its talcum powder and has convened a grand jury in Washington, Bloomberg reported on Friday, citing people with knowledge of the matter.

Jul 12 2019

California to take J&J to trial over mesh implant marketing

California on Monday will be the first state to take Johnson & Johnson to trial over allegations that it misrepresented the risks of serious conditions women using its pelvic mesh devices could develop.

Jul 12 2019

Earnings vs. Estimates